AAAAAA

   
Results: 1-16 |
Results: 16
DOES RALOXIFENE ANALOG (LY117018) MAINTAIN THE GAIN IN BONE MASS SEENIN OSTEOPENIC OVARIECTOMIZED RATS AN ANABOLIC REGIMEN OF COMBINED WITH RALOXIFENE
Authors: WATSON P DROST D THORNTON M HOLDSWORTH D FRAHER L HODSMAN A HOCK J BRYANT H
Citation: P. Watson et al., DOES RALOXIFENE ANALOG (LY117018) MAINTAIN THE GAIN IN BONE MASS SEENIN OSTEOPENIC OVARIECTOMIZED RATS AN ANABOLIC REGIMEN OF COMBINED WITH RALOXIFENE, Journal of bone and mineral research, 12, 1997, pp. 486-486
DOES THE ADDITION OF RALOXIFENE ANALOG (LY117018) ALLOW FOR REDUCED PTH DOSING DURING REVERSAL OF OSTEOPENIA IN THE OVARIECTOMIZED RAT
Authors: WATSON P DROST D THORNTON M HOLDSWORTH D FRAHER L HODSMAN A HOCK J BRYANT H
Citation: P. Watson et al., DOES THE ADDITION OF RALOXIFENE ANALOG (LY117018) ALLOW FOR REDUCED PTH DOSING DURING REVERSAL OF OSTEOPENIA IN THE OVARIECTOMIZED RAT, Journal of bone and mineral research, 12, 1997, pp. 489-489
RAPID SMALL ANIMAL DEXA USING AN AREA DETECTOR
Authors: THORNTON M HOLDSWORTH D WATSON P FRAHER L HODSMAN A DROST D
Citation: M. Thornton et al., RAPID SMALL ANIMAL DEXA USING AN AREA DETECTOR, Journal of bone and mineral research, 12, 1997, pp. 639-639
INTERMITTENT ETIDRONATE THERAPY TO PREVENT CORTICOSTEROID-INDUCED OSTEOPOROSIS
Authors: ADACHI JD BENSEN WG BROWN J HANLEY D HODSMAN A JOSSE R KENDLER DL LENTLE B OLSZYNSKI W STEMARIE LG TENENHOUSE A CHINES AA
Citation: Jd. Adachi et al., INTERMITTENT ETIDRONATE THERAPY TO PREVENT CORTICOSTEROID-INDUCED OSTEOPOROSIS, The New England journal of medicine, 337(6), 1997, pp. 382-387
ASSESSING RESPONSE TO ETIDRONATE IN OSTEOPOROSIS
Authors: CRILLY R HODSMAN A PLATT N COOK C
Citation: R. Crilly et al., ASSESSING RESPONSE TO ETIDRONATE IN OSTEOPOROSIS, Journal of bone and mineral research, 11, 1996, pp. 643-643
USE OF BISPHOSPHONATES IN THE TREATMENT OF OSTEOPOROSIS
Authors: HODSMAN A ADACHI J OLSZYNSKI W
Citation: A. Hodsman et al., USE OF BISPHOSPHONATES IN THE TREATMENT OF OSTEOPOROSIS, CMAJ. Canadian Medical Association journal, 155(7), 1996, pp. 945-948
PREDICTING RESPONSE TO ETIDRONATE IN OSTEOPOROSIS
Authors: CRILLY R HODSMAN A PLATT N COOK C ADACHI J
Citation: R. Crilly et al., PREDICTING RESPONSE TO ETIDRONATE IN OSTEOPOROSIS, Arthritis and rheumatism, 39(9), 1996, pp. 664-664
PARATHYROID-HORMONE RESTORES BONE MASS AND ENHANCES OSTEOBLAST INSULIN-LIKE GROWTH-FACTOR-I GENE-EXPRESSION IN OVARIECTOMIZED RATS
Authors: WATSON P LAZOWSKI D HAN V FRAHER L STEER B HODSMAN A
Citation: P. Watson et al., PARATHYROID-HORMONE RESTORES BONE MASS AND ENHANCES OSTEOBLAST INSULIN-LIKE GROWTH-FACTOR-I GENE-EXPRESSION IN OVARIECTOMIZED RATS, Bone, 16(3), 1995, pp. 357-365
A QUESTIONNAIRE TO EVALUATE DISABILITY IN OSTEOPOROTIC PATIENTS WITH VERTEBRAL COMPRESSION FRACTURES
Authors: HELMES E HODSMAN A LAZOWSKI D BHARDWAJ A CRILLY R NICHOL P DROST D VANDERBURGH L PEDERSON L
Citation: E. Helmes et al., A QUESTIONNAIRE TO EVALUATE DISABILITY IN OSTEOPOROTIC PATIENTS WITH VERTEBRAL COMPRESSION FRACTURES, The journals of gerontology. Series A, Biological sciences and medical sciences, 50(2), 1995, pp. 91-98
A CLINICAL-TRIAL OF CYCLICAL CLODRONATE AS MAINTENANCE THERAPY FOLLOWING WITHDRAWAL OF PARATHYROID-HORMONE, IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS
Authors: HODSMAN A FRAHER L ADACHI J
Citation: A. Hodsman et al., A CLINICAL-TRIAL OF CYCLICAL CLODRONATE AS MAINTENANCE THERAPY FOLLOWING WITHDRAWAL OF PARATHYROID-HORMONE, IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS, Journal of bone and mineral research, 10, 1995, pp. 200-200
VERTEBRAL BONE-MINERAL DENSITY (VBMD) AMONG ELDERLY MEN AND WOMEN RECEIVING LONG-TERM INHALED (I-S) OR ORAL STEROIDS (O-S) FOR ASTHMA
Authors: TOOGOOD J HODSMAN A BASKERVILLE J MARKOV A
Citation: J. Toogood et al., VERTEBRAL BONE-MINERAL DENSITY (VBMD) AMONG ELDERLY MEN AND WOMEN RECEIVING LONG-TERM INHALED (I-S) OR ORAL STEROIDS (O-S) FOR ASTHMA, Journal of allergy and clinical immunology, 95(1), 1995, pp. 310-310
A COMPARISON OF THE EFFICACY AND SYSTEMIC EFFECTS OF BUDESONIDE (BUD)ADMINISTERED AS AN AEROSOL VIA METERED-DOSE INHALER (MDI) PLUS NEBUHALER AND AS A DRY POWDER VIA TURBUHALER (TBH)
Authors: WHITE FA TOOGOOD JH BASKERVILLE J HODSMAN A
Citation: Fa. White et al., A COMPARISON OF THE EFFICACY AND SYSTEMIC EFFECTS OF BUDESONIDE (BUD)ADMINISTERED AS AN AEROSOL VIA METERED-DOSE INHALER (MDI) PLUS NEBUHALER AND AS A DRY POWDER VIA TURBUHALER (TBH), Journal of allergy and clinical immunology, 95(1), 1995, pp. 312-312
REGIONAL VARIATION OF INSULIN-LIKE GROWTH-FACTOR-I GENE-EXPRESSION INMATURE RAT BONE AND CARTILAGE
Authors: LAZOWSKI DA FRAHER LJ HODSMAN A STEER B MODROWSKI D HAN VKM
Citation: Da. Lazowski et al., REGIONAL VARIATION OF INSULIN-LIKE GROWTH-FACTOR-I GENE-EXPRESSION INMATURE RAT BONE AND CARTILAGE, Bone, 15(5), 1994, pp. 563-576
ASSOCIATIONS OF LONG-TERM INHALED STEROID (I-S) AND ORAL PREDNISONE (PRED) THERAPY WITH VERTEBRAL FRACTURE IN ASTHMATIC ADULTS
Authors: BASKERVILLE J HODSMAN A TOOGOOD J HADDAD R MARKOV A
Citation: J. Baskerville et al., ASSOCIATIONS OF LONG-TERM INHALED STEROID (I-S) AND ORAL PREDNISONE (PRED) THERAPY WITH VERTEBRAL FRACTURE IN ASTHMATIC ADULTS, Journal of allergy and clinical immunology, 93(1), 1994, pp. 200-200
EFFECTS OF LONG-TERM INHALED STEROID (I-S) AND ORAL STEROID (O-S) THERAPY ON BONE-MINERAL DENSITY (BMD) IN ASTHMATIC ADULTS
Authors: TOOGOOD JH BASKERVILLE J HODSMAN A FRAHER L MARKOV A
Citation: Jh. Toogood et al., EFFECTS OF LONG-TERM INHALED STEROID (I-S) AND ORAL STEROID (O-S) THERAPY ON BONE-MINERAL DENSITY (BMD) IN ASTHMATIC ADULTS, Journal of allergy and clinical immunology, 93(1), 1994, pp. 200-200
LOCALIZATION OF OSTEOCALCIN, AND IGF-I PEPTIDE AND MESSENGER-RNA IN OSTEOBLASTS FROM OOPHORECTOMIZED RATS TREATED WITH PARATHYROID-HORMONE
Authors: STEER B HODSMAN A FRAHER L MODROWSKI D HAN V
Citation: B. Steer et al., LOCALIZATION OF OSTEOCALCIN, AND IGF-I PEPTIDE AND MESSENGER-RNA IN OSTEOBLASTS FROM OOPHORECTOMIZED RATS TREATED WITH PARATHYROID-HORMONE, Journal of bone and mineral research, 8, 1993, pp. 190000361-190000361
Risultati: 1-16 |